Mirae Asset Global Investments Co., Ltd. Omeros Corp Transaction History

Mirae Asset Global Investments Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$2.81 - $5.69 $160 - $324	57 Added 0.18%	32,205 $94,000
Q2 2023 Aug 10, 2023	BUY	$4.45 - $7.57 $143,058 - $243,360	32,148 New	32,148 $174,000
Q2 2022 Jul 26, 2022	SELL	$1.92 - $6.28 $20,808 - $68,062	-10,838 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$5.07 - $7.2 $4,350 - $6,177	-858 Reduced 7.34%	10,838 $65,000
Q4 2021 Feb 08, 2022	BUY	$5.67 - $8.54 $1,394 - $2,100	246 Added 2.15%	11,696 $75,000
Q3 2021 Nov 15, 2021	BUY	$13.4 - $16.3 $15,570 - $18,940	1,162 Added 11.29%	11,450 $158,000
Q2 2021 Aug 11, 2021	BUY	$14.81 - $19.13 $152,365 - $196,809	10,288 New	10,288 $153,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $747M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.